Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.77 -0.02 (-2.53%)
As of: Oct 21, 2026 · 11:49 AM EDT

Brainstorm Cell Therapeutics (BCLI) Depreciation and Depletion (2016 - 2026)

Updated

Brainstorm Cell Therapeutics (BCLI) posted Depreciation and Depletion of $46,000 for Q2 2026, down 9.8% from $51,000 a year earlier but up 24.3% from the prior quarter.

Analysis

Brainstorm Cell Therapeutics (BCLI) Depreciation and Depletion (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation and Depletion at Brainstorm Cell Therapeutics was $179,000, down 16.7% year-over-year; for FY2025, it was $199,000, down 17.1% from FY2024.

  • Annual Depreciation and Depletion has declined for three consecutive years, with a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
  • In prior years, Brainstorm Cell Therapeutics' Depreciation and Depletion was $240,000 in FY2024 (-9.4%), $265,000 in FY2023 (-7.0%), $285,000 in FY2022 (+9.6%) and $260,000 in FY2021 (+18.7%).
  • Quarterly Depreciation and Depletion has run from a low of $37,000 in Q1 2026 to a high of $74,000 in Q1 2022 over five years.
  • On a year-over-year basis, Depreciation and Depletion has declined in each of the last 14 quarters, with an average decline of 16.8% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation and Depletion in the past five years was Q1 2022, with growth of 21.3%; the weakest was Q1 2026, with a decline of 28.8%.
  • According to Business Quant data, Depreciation and Depletion for the three prior quarters was $37,000 (Q1 2026), $48,000 (Q4 2025) and $48,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 194.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 98.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Brainstorm Cell Therapeutics 8.50 Mn 8.43 Mn - 46,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46,000.00
Mar 31, 2026 37,000.00
Dec 31, 2025 48,000.00
Sep 30, 2025 48,000.00
Jun 30, 2025 51,000.00
Mar 31, 2025 52,000.00
Dec 31, 2024 53,000.00
Sep 30, 2024 59,000.00
Jun 30, 2024 64,000.00
Mar 31, 2024 64,000.00
Dec 31, 2023 66,000.00
Sep 30, 2023 65,000.00
Jun 30, 2023 67,000.00
Mar 31, 2023 67,000.00
Dec 31, 2022 70,000.00
Sep 30, 2022 70,000.00
Jun 30, 2022 71,000.00
Mar 31, 2022 74,000.00
Dec 31, 2021 70,000.00
Sep 30, 2021 67,000.00
API Access

Brainstorm Cell Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=BCLI&period=max&api_key=YOUR_API_KEY